Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Identification of Therapeutic Targets for Chemoresistant Triple-Negative Breast Cancer

EF 2016-17

Résumé
Triple-negative breast cancer (TNBC) is known to be particularly aggressive and difficult to treat, as it lacks specific therapeutic targets, such as growth and hormonal receptors. Additionally, TNBC recurs at a high rate in previously diagnosed patients and is often accompanied by chemoresistance. In fact, 90% of drug therapies fail to treat metastatic cancer due to chemoresistance. I hypothesize that hypoxia, cancer stem-like cells (CSCs), and epithelial-mesenchymal transition (EMT) play critical roles in the chemoresistance of TNBC. The goal of my research is to establish a link between chemoresistance, hypoxic tumour microenvironments, CSCs, and EMT using a candidate targeted approach. The three main objectives of the research project include: developing models of chemoresistance in human and murine TNBC cells lines; the analysis of hypoxia-induced genes regulating EMT and differentially expressed genes of CSCs; and the selective knockdown of these differentially expressed genes to affect TNBC chemosensitivity. This project has the potential for the identification of genes that not only regulate the TNBC phenotype but also promote chemoresistance. The work will identify key targetable pathways for reversing chemoresistance and thus increasing the effectiveness of current treatments.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
367271
Name
Nagel Jennifer
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identification of Therapeutic Targets for Chemoresistant Triple-Negative Breast Cancer
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biochemistry; Breast Cancer; Cellular Biology; Chemoresistance; Chemotherapy; Cisplatin; Health; Molecular Biology; Oncology; Paclitaxel
Abstract
Triple-negative breast cancer (TNBC) is known to be particularly aggressive and difficult to treat, as it lacks specific therapeutic targets, such as growth and hormonal receptors. Additionally, TNBC recurs at a high rate in previously diagnosed patients and is often accompanied by chemoresistance. In fact, 90% of drug therapies fail to treat metastatic cancer due to chemoresistance. I hypothesize that hypoxia, cancer stem-like cells (CSCs), and epithelial-mesenchymal transition (EMT) play critical roles in the chemoresistance of TNBC. The goal of my research is to establish a link between chemoresistance, hypoxic tumour microenvironments, CSCs, and EMT using a candidate targeted approach. The three main objectives of the research project include: developing models of chemoresistance in human and murine TNBC cells lines; the analysis of hypoxia-induced genes regulating EMT and differentially expressed genes of CSCs; and the selective knockdown of these differentially expressed genes to affect TNBC chemosensitivity. This project has the potential for the identification of genes that not only regulate the TNBC phenotype but also promote chemoresistance. The work will identify key targetable pathways for reversing chemoresistance and thus increasing the effectiveness of current treatments.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Nagel, Jennifer
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~